PharmEng Reports Reduced Cash Burn, Financing Update, Strategic … - MarketWatch

PharmEng Reports Reduced Cash Burn, Financing Update, Strategic
MarketWatch -1 hour ago
As a result of the significant capacity added through the Arnprior facility acquisition, new manufacturing volumes will now be allocated between two

More: continued here

Leave a Comment for PharmEng Reports Reduced Cash Burn, Financing Update, Strategic … - MarketWatch